Equibles does not estimate personal net worth.
Get an email with a short summary when Arcus Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get RCUS alertsRobert Goeltz is recorded as CFO at Arcus Biosciences, Inc. (RCUS). The newest filing on record that lists Robert Goeltz as CFO at Arcus Biosciences, Inc. (RCUS) is dated April 21, 2026. Robert Goeltz has spoken on 2 earnings calls across 1 company, most recently for Arcus Biosciences, Inc. on November 7, 2023. Arcus Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcus Biosciences, Inc. includes Terry Rosen (CEO and Board Member), Robert C. Goeltz II (CFO and Chief Accounting Officer), Jennifer Jarrett (COO) and 7 others.
“Arcus continues to be in a very strong financial position. Our cash at the end of September 30th, 2023 was $950 million, and our net cash utilization through three-quarters of 2023 has been $188 million.”
“I'll touch on a few of the highlights from our second quarter 2021 financial results. For more details regarding our results, please refer to our earnings press release from earlier today and our 10-Q. Arcus continues to be in a strong financial position.”
Start not stated–present
Last confirmed April 21, 2026
Biotechnology · Healthcare
CFO
